InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Genentech’s biosimilar complaint against Amgen dismissed

Michael Loney, New York


Judge Sleet of the District of Delaware has dismissed Genentech’s biosimilar complaint against Amgen for lack of subject matter jurisdiction, and granted 45 days for an amended complaint to be filed

Genentech’s complaint alleging Amgen failed to comply with the Biologics Price Competition and Innovation Act (BPCIA) has been dismissed by Judge Sleet of the District of Delaware. Sleet dismissed the complaint without prejudice on March 1 and gave Genentech 45...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Most read articles

Latest Country Updates

Supplements